129 related articles for article (PubMed ID: 34166718)
21. Chest wall volume receiving >30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy.
Dunlap NE; Cai J; Biedermann GB; Yang W; Benedict SH; Sheng K; Schefter TE; Kavanagh BD; Larner JM
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):796-801. PubMed ID: 19427740
[TBL] [Abstract][Full Text] [Related]
22. Normal tissue complication probability modeling for acute esophagitis in patients treated with conformal radiation therapy for non-small cell lung cancer.
Chapet O; Kong FM; Lee JS; Hayman JA; Ten Haken RK
Radiother Oncol; 2005 Nov; 77(2):176-81. PubMed ID: 16256230
[TBL] [Abstract][Full Text] [Related]
23. Stereotactic body radiation therapy of lung tumors: preliminary experience using normal tissue complication probability-based dose limits.
Song DY; Benedict SH; Cardinale RM; Chung TD; Chang MG; Schmidt-Ullrich RK
Am J Clin Oncol; 2005 Dec; 28(6):591-6. PubMed ID: 16317270
[TBL] [Abstract][Full Text] [Related]
24. Effect of Tumor Location and Dosimetric Predictors for Chest Wall Toxicity in Single-Fraction Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer.
Manyam BV; Videtic GMM; Verdecchia K; Reddy CA; Woody NM; Stephans KL
Pract Radiat Oncol; 2019 Mar; 9(2):e187-e195. PubMed ID: 30529796
[TBL] [Abstract][Full Text] [Related]
25. Correlation of clinical outcome, radiobiological modeling of tumor control, normal tissue complication probability in lung cancer patients treated with SBRT using Monte Carlo calculation algorithm.
Sood SS; Pokhrel D; Badkul R; TenNapel M; McClinton C; Kimler B; Wang F
J Appl Clin Med Phys; 2020 Oct; 21(10):56-62. PubMed ID: 32794632
[TBL] [Abstract][Full Text] [Related]
26. Pathological vertebral fracture after stereotactic body radiation therapy for lung metastases. Case report and literature review.
Rodríguez-Ruiz ME; San Miguel I; Gil-Bazo I; Perez-Gracia JL; Arbea L; Moreno-Jimenez M; Aristu J
Radiat Oncol; 2012 Mar; 7():50. PubMed ID: 22455311
[TBL] [Abstract][Full Text] [Related]
27. Proton beam radiotherapy versus three-dimensional conformal stereotactic body radiotherapy in primary peripheral, early-stage non-small-cell lung carcinoma: a comparative dosimetric analysis.
Macdonald OK; Kruse JJ; Miller JM; Garces YI; Brown PD; Miller RC; Foote RL
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(3):950-8. PubMed ID: 19801106
[TBL] [Abstract][Full Text] [Related]
28. Dose-volume histogram analysis for risk factors of radiation-induced rib fracture after hypofractionated proton beam therapy for hepatocellular carcinoma.
Kanemoto A; Mizumoto M; Okumura T; Takahashi H; Hashimoto T; Oshiro Y; Fukumitsu N; Moritake T; Tsuboi K; Sakae T; Sakurai H
Acta Oncol; 2013 Apr; 52(3):538-44. PubMed ID: 22950386
[TBL] [Abstract][Full Text] [Related]
29. Modeling radiation pneumonitis of pulmonary stereotactic body radiotherapy: The impact of a local dose-effect relationship for lung perfusion loss.
Selvaraj J; Lebesque J; Hope A; Guckenberger M; Werner-Wasik M; Peulen H; Giuliani M; Mantel F; Belderbos J; Grills I; Sonke JJ
Radiother Oncol; 2019 Mar; 132():142-147. PubMed ID: 30825963
[TBL] [Abstract][Full Text] [Related]
30. Dose-volume parameters predict for the development of chest wall pain after stereotactic body radiation for lung cancer.
Mutter RW; Liu F; Abreu A; Yorke E; Jackson A; Rosenzweig KE
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1783-90. PubMed ID: 21868173
[TBL] [Abstract][Full Text] [Related]
31. Predictors and characteristics of Rib fracture following SBRT for lung tumors.
Carducci MP; Sundaram B; Greenberger BA; Werner-Wasik M; Kane GC
BMC Cancer; 2023 Apr; 23(1):337. PubMed ID: 37046249
[TBL] [Abstract][Full Text] [Related]
32. Rib fracture after stereotactic radiotherapy for primary lung cancer: prevalence, degree of clinical symptoms, and risk factors.
Nambu A; Onishi H; Aoki S; Tominaga L; Kuriyama K; Araya M; Saito R; Maehata Y; Komiyama T; Marino K; Koshiishi T; Sawada E; Araki T
BMC Cancer; 2013 Feb; 13():68. PubMed ID: 23391264
[TBL] [Abstract][Full Text] [Related]
33. Radiobiological impact of dose calculation algorithms on biologically optimized IMRT lung stereotactic body radiation therapy plans.
Liang X; Penagaricano J; Zheng D; Morrill S; Zhang X; Corry P; Griffin RJ; Han EY; Hardee M; Ratanatharathom V
Radiat Oncol; 2016 Jan; 11():10. PubMed ID: 26800883
[TBL] [Abstract][Full Text] [Related]
34. Predictors of Chest Wall Toxicity after Lung Stereotactic Ablative Radiotherapy.
Thibault I; Chiang A; Erler D; Yeung L; Poon I; Kim A; Keller B; Lochray F; Jain S; Soliman H; Cheung P
Clin Oncol (R Coll Radiol); 2016 Jan; 28(1):28-35. PubMed ID: 26129745
[TBL] [Abstract][Full Text] [Related]
35. Chest wall toxicity after stereotactic body radiotherapy for malignant lesions of the lung and liver.
Andolino DL; Forquer JA; Henderson MA; Barriger RB; Shapiro RH; Brabham JG; Johnstone PA; Cardenes HR; Fakiris AJ
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):692-7. PubMed ID: 21288656
[TBL] [Abstract][Full Text] [Related]
36. [Relationship of dose-volume histogram parameters and computed tomography grading of radiation-induced lung injury in patients with non-small cell lung cancer treated by three-dimensional conformal radiotherapy].
Xing J; Li JB; Yu JM; Lu J; Xu M; Fan TY; Shao Q; Guo SF
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):676-81. PubMed ID: 19173909
[TBL] [Abstract][Full Text] [Related]
37. Chest wall pain and rib fracture after stereotactic radiotherapy for peripheral non-small cell lung cancer.
Voroney JP; Hope A; Dahele MR; Purdie TG; Franks KN; Pearson S; Cho JB; Sun A; Payne DG; Bissonnette JP; Bezjak A; Brade AM
J Thorac Oncol; 2009 Aug; 4(8):1035-7. PubMed ID: 19633478
[TBL] [Abstract][Full Text] [Related]
38. NTCP modelling of lung toxicity after SBRT comparing the universal survival curve and the linear quadratic model for fractionation correction.
Wennberg BM; Baumann P; Gagliardi G; Nyman J; Drugge N; Hoyer M; Traberg A; Nilsson K; Morhed E; Ekberg L; Wittgren L; Lund JÅ; Levin N; Sederholm C; Lewensohn R; Lax I
Acta Oncol; 2011 May; 50(4):518-27. PubMed ID: 21198416
[TBL] [Abstract][Full Text] [Related]
39. Normal tissue complication probability of vertebral compression fracture after stereotactic body radiotherapy for de novo spine metastasis.
Chen X; Gui C; Grimm J; Huang E; Kleinberg L; Lo L; Sciubba D; Khan M; Redmond KJ
Radiother Oncol; 2020 Sep; 150():142-149. PubMed ID: 32540335
[TBL] [Abstract][Full Text] [Related]
40. Calculating the individualized fraction regime in stereotactic body radiotherapy for non-small cell lung cancer based on uncomplicated tumor control probability function.
Lu JY; Lin PX; Huang BT
Radiat Oncol; 2019 Jun; 14(1):111. PubMed ID: 31221159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
